Why Moderna Just Booked Another $3 Billion in Vaccine Orders and No One Cared
Any way you look at it, Moderna (NASDAQ: MRNA) is on a roll. Its shares skyrocketed more than 430% last year. The stock has close to doubled so far in 2021.
Moderna keeps reporting more good news on a regular basis. Usually, the company's announcements serve as solid positive catalysts for the biotech stock. That's not always the case, though. Here's why Moderna just booked another $3 billion in vaccine orders and no one seemed to care.
Image source: Getty Images.
Source Fool.com
